Paul Modafferi, ARNP

Paul Modafferi practices at Capital Regional Healthcare in Tallahassee, Florida.

Paul Modafferi's NPI, 1760880082, was assigned on December 18, 2014. Paul Modafferi holds Florida license ARNP9188795.

Paul Modafferi's primary practice is Capital Regional Healthcare, at 1910 Hillbrooke Trl, Tallahassee, FL 32311 in Leon County. The practice phone is (850) 877-0910.

Paul Modafferi's primary practice is Capital Regional Healthcare in Tallahassee, Florida. The medical group on file is HCA Florida Capital Vascular Surgery. Dmand AI also links Paul Modafferi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Modafferi practices. Vendor and product names are available with a free account.

Family is Paul Modafferi's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Paul Modafferi is licensed in Florida.

Dmand AI lists acute skin infection, anxiety, chronic diabetes, chronic obstructive pulmonary disease (COPD), ear infection, intellectual and developmental disabilities, rash and upper respiratory infection (URI) among the conditions Paul Modafferi treats.

CMS data shows 348 Medicare services from Paul Modafferi across 7 procedure codes in 2024, for 114 Medicare patients. Medicare paid $16,904 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Paul Modafferi in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Paul Modafferi's median patient age at 62, with 55% women.

In 2024, Paul Modafferi wrote 9,327 Medicare Part D claims for 915 patients. 83% of them were for generic drugs. CMS names the drug for 8,639 of them, across 145 drugs with 11 or more claims each, at $1,167,419 in total drug cost.

Paul Modafferi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 265 general payments to Paul Modafferi from 24 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $786.